These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 37192002)
1. Viral vector-mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome. Fadila S; Beucher B; Dopeso-Reyes IG; Mavashov A; Brusel M; Anderson K; Ismeurt C; Goldberg EM; Ricobaraza A; Hernandez-Alcoceba R; Kremer EJ; Rubinstein M J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37192002 [TBL] [Abstract][Full Text] [Related]
2. Targeted Augmentation of Nuclear Gene Output (TANGO) of Scn1a rescues parvalbumin interneuron excitability and reduces seizures in a mouse model of Dravet Syndrome. Wengert ER; Wagley PK; Strohm SM; Reza N; Wenker IC; Gaykema RP; Christiansen A; Liau G; Patel MK Brain Res; 2022 Jan; 1775():147743. PubMed ID: 34843701 [TBL] [Abstract][Full Text] [Related]
3. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome. Niibori Y; Lee SJ; Minassian BA; Hampson DR Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809 [TBL] [Abstract][Full Text] [Related]
4. Cell-Selective Adeno-Associated Virus-Mediated Tanenhaus A; Stowe T; Young A; McLaughlin J; Aeran R; Lin IW; Li J; Hosur R; Chen M; Leedy J; Chou T; Pillay S; Vila MC; Kearney JA; Moorhead M; Belle A; Tagliatela S Hum Gene Ther; 2022 Jun; 33(11-12):579-597. PubMed ID: 35435735 [TBL] [Abstract][Full Text] [Related]
5. A novel rat model of Dravet syndrome recapitulates clinical hallmarks. Li M; Yang L; Qian W; Ray S; Lu Z; Liu T; Zou YY; Naumann RK; Wang H Neurobiol Dis; 2023 Aug; 184():106193. PubMed ID: 37295561 [TBL] [Abstract][Full Text] [Related]
6. Convulsive seizures and some behavioral comorbidities are uncoupled in the Scn1a Fadila S; Quinn S; Turchetti Maia A; Yakubovich D; Ovadia M; Anderson KL; Giladi M; Rubinstein M Epilepsia; 2020 Oct; 61(10):2289-2300. PubMed ID: 32865826 [TBL] [Abstract][Full Text] [Related]
7. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development. Tsai MS; Lee ML; Chang CY; Fan HH; Yu IS; Chen YT; You JY; Chen CY; Chang FC; Hsiao JH; Khorkova O; Liou HH; Yanagawa Y; Lee LJ; Lin SW Neurobiol Dis; 2015 May; 77():35-48. PubMed ID: 25725421 [TBL] [Abstract][Full Text] [Related]
8. Chronic partial TrkB activation reduces seizures and mortality in a mouse model of Dravet syndrome. Gu F; Parada I; Yang T; Longo FM; Prince DA Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35165147 [TBL] [Abstract][Full Text] [Related]
9. A high seizure burden increases several prostaglandin species in the hippocampus of a Scn1a Zhou C; Satpute V; Yip KL; Anderson LL; Hawkins N; Kearney J; Arnold JC Prostaglandins Other Lipid Mediat; 2024 Jun; 172():106836. PubMed ID: 38599513 [TBL] [Abstract][Full Text] [Related]
11. A selective Na Chow CY; Chin YKY; Ma L; Undheim EAB; Herzig V; King GF Biochem Pharmacol; 2020 Nov; 181():113991. PubMed ID: 32335140 [TBL] [Abstract][Full Text] [Related]
12. Astrocyte Ca Uchino K; Tanaka Y; Ikezawa W; Deshimaru M; Kubota K; Watanabe T; Katsurabayashi S; Iwasaki K; Hirose S Biochem Biophys Res Commun; 2023 Feb; 643():169-174. PubMed ID: 36610382 [TBL] [Abstract][Full Text] [Related]
13. Tau reduction prevents disease in a mouse model of Dravet syndrome. Gheyara AL; Ponnusamy R; Djukic B; Craft RJ; Ho K; Guo W; Finucane MM; Sanchez PE; Mucke L Ann Neurol; 2014 Sep; 76(3):443-56. PubMed ID: 25042160 [TBL] [Abstract][Full Text] [Related]
14. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome. Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343 [TBL] [Abstract][Full Text] [Related]
15. Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current. Schutte RJ; Schutte SS; Algara J; Barragan EV; Gilligan J; Staber C; Savva YA; Smith MA; Reenan R; O'Dowd DK J Neurophysiol; 2014 Aug; 112(4):903-12. PubMed ID: 24805083 [TBL] [Abstract][Full Text] [Related]
16. Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. Makinson CD; Tanaka BS; Lamar T; Goldin AL; Escayg A Neurobiol Dis; 2014 Aug; 68():16-25. PubMed ID: 24704313 [TBL] [Abstract][Full Text] [Related]
17. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome. Miller AR; Hawkins NA; McCollom CE; Kearney JA Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123 [TBL] [Abstract][Full Text] [Related]
18. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq. Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticle encapsulated oxytocin increases resistance to induced seizures and restores social behavior in Scn1a-derived epilepsy. Wong JC; Shapiro L; Thelin JT; Heaton EC; Zaman RU; D'Souza MJ; Murnane KS; Escayg A Neurobiol Dis; 2021 Jan; 147():105147. PubMed ID: 33189882 [TBL] [Abstract][Full Text] [Related]